Blue Jet Healthcare Limited (BLUEJET.NS)
INR 584.5
(1.93%)
INR 584.5
(1.93%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 16.12 Million INR | -67.35% |
| 2022 | 49.4 Million INR | -73.75% |
| 2021 | 188.17 Million INR | -64.57% |
| 2020 | 531.15 Million INR | -31.52% |
| 2019 | 775.65 Million INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 10.78 Million INR | 0.0% |
| 2024 Q1 | - INR | -100.0% |
| 2023 FY | 16.12 Million INR | -67.35% |
| 2023 Q1 | 39.89 Million INR | 15.96% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 20.95 Million INR | -47.48% |
| 2023 Q4 | 16.12 Million INR | 0.0% |
| 2022 Q1 | 197.36 Million INR | 0.0% |
| 2022 Q4 | 34.4 Million INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Biocon Limited | 162.76 Billion INR | 99.99% |
| Concord Biotech Limited | 97.37 Million INR | 83.435% |
| Dishman Carbogen Amcis Limited | 23.12 Billion INR | 99.93% |
| Jubilant Ingrevia Limited | 7.4 Billion INR | 99.782% |
| Lyka Labs Limited | 586.5 Million INR | 97.25% |
| Panacea Biotec Limited | 209.9 Million INR | 92.315% |
| Piramal Pharma Limited | 47.1 Billion INR | 99.966% |
| SMS Lifesciences India Limited | 1 Billion INR | 98.399% |
| Supriya Lifescience Limited | 54.88 Million INR | 70.609% |
| Syngene International Limited | 5.55 Billion INR | 99.709% |
| TAKE Solutions Limited | 370.85 Million INR | 95.651% |
| Zota Health Care Limited | 952.84 Million INR | 98.307% |